Impact Factor 3.845 | CiteScore 3.92
More on impact ›

Correction ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Pharmacol. | doi: 10.3389/fphar.2019.01036

Correction: Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics

  • 1College of Pharmacy, Dalian Medical University, China

The authors regret in the article referenced above. In Figure 6A, the effect of shRNA + dio 5.0 μg/mL on SDC-4 expression level based on immunofluorescence assay were repeatedly pasted to Figure 4A (dio 2.5 μg/mL group) due to negligence.In the corrigendum Figure 6A, we have provided the correct result of shRNA+ dio 5.0 μg/mL group, which showed no influence to the results. All authors of the paper are aware of the errors and have agreed to the correction. The authors regret and apologize for any inconvenience to readers arising from the errors.

Keywords: cell migration, dioscin, Hepatic Stellate Cells, iTRAQ, Syndecan-4

Received: 08 Aug 2019; Accepted: 14 Aug 2019.

Copyright: © 2019 Yin, Yan, Xu, Xu, Han, Tao, Song and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. Jinyong Peng, College of Pharmacy, Dalian Medical University, Dalian, China,